Noile-Immune Biotech

About:

Noile-Immune Biotech is a national cancer research center specializing in the development of cancer immunotherapies.

Website: https://www.noile-immune.com

Top Investors: Takeda, Dai-ichi Life, DCI Partners, Healthcare Innovation, SAIKYO

Description:

Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.

Total Funding Amount:

3.44B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2015-04-16

Contact Email:

info(AT)noile-immune.com

Founders:

Hidenobu Ishizaki

Number of Employees:

11-50

Last Funding Date:

2021-03-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai